查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物资讯市场－全球及区域分析：按产品/服务、产业、应用和地区划分－分析与预测（2025-2035）
市场调查报告书
商品编码
1885394

生物资讯市场－全球及区域分析：按产品/服务、产业、应用和地区划分－分析与预测（2025-2035）

Bioinformatics Market - A Global and Regional Analysis: Focus on Product and Services, Sector, Application, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 146 Pages | 商品交期: 1-5个工作天内

价格

全球生物资讯市场预计到 2024 年将达到 142.3 亿美元，到 2035 年将显着成长至 555.4 亿美元。

这意味着从 2025 年到 2035 年，复合年增长率将达到 13.21%。

关键市场统计数据
预测期 2025-2035
截至2025年的估值 160.6亿美元
2035 年预测 555.4亿美元
复合年增长率 13.21%

生物资讯学是一门交叉学科，它结合了生物学、化学、数学、统计学和计算机科学，用于分析复杂的生物数据。生物资讯学对于理解生物分子的结构、功能和演化至关重要，并在识别疾病的遗传病因、分析基因表现和研究蛋白质相互作用方面发挥关键作用。它对于药物发现、个人化医疗和阐明代谢通路也至关重要。次世代定序技术的进步导致基因组数据爆炸性成长，大大推动了对生物资讯工具的需求。此外，生物资讯学在精准医疗上的应用也日益广泛。人工智慧和机器学习的持续进步进一步提高了数据分析的准确性和速度，使生物资讯学成为未来医疗保健、基因组学和生命科学研究的关键组成部分，其重要性与日俱增。

市场概览

生物资讯市场正经历快速发展，其驱动力来自技术创新以及基因组学和个人化医疗领域不断增长的投资。 Illumina、Thermo Fisher Scientific 和 QIAGEN 等主要企业提供尖端的定序平台和数据分析工具，引领着生物资讯解决方案的变革，正在改变医疗保健和製药行业。策略联盟和收购也在市场成长中发挥关键作用。例如，Illumina 正在扩大其在亚太地区的商业版图，而 Thermo Fisher Scientific 则持续创新，开髮用于基因组数据分析的云端基础生物资讯解决方案。此外，Tempus 和 23andMe 等公司正在整合生物资讯学工具，用于精准医疗和消费者导向的基因检测，推动生物资讯学在各个应用领域的普及。这些发展表明，市场对先进生物资讯解决方案的需求日益增长，有助于加速创新，并扩大基因组学、药物研发和个人化医疗领域的应用范围。

对产业的影响

生物资讯市场正经历重大变革，赛默飞世尔主要企业 Inc.）、Illumina公司、安捷伦科技公司（Agilent Technologies）和凯杰公司（QIAGEN）等产业巨头正推动着生物资讯技术的进步。这些领导企业透过整合人工智慧（AI）、机器学习和云端运算等尖端技术，不断突破创新边界，提升生物资讯学能力。人工智慧与生物资讯学的融合正在革新复杂生物数据的分析方式，使研究人员和临床医生能够在基因组学、蛋白质组学和个人化医疗领域中获得更快、更准确的洞见。

人工智慧驱动的生物资讯工具正在实现数据处理和分析的自动化，从而减少人为错误并缩短研发週期。例如，人工智慧模型可以分析海量基因组资料集，并识别出与疾病相关的模式和突变，而使用传统方法则需要花费更长时间才能发现这些模式和突变。这种快速分析对于推进精准医疗至关重要，精准医疗是指根据个别患者的基因谱量身定制治疗方案。此外，机器学习演算法正在增强预测模型，从而在药物发现和患者预后方面实现更准确的预测。

云端运算在生物资讯领域的应用也带来了变革性的影响，实现了全球研究团队之间无缝的资料共用、储存和协作。这不仅加速了基因组学和药物研发，还透过提供扩充性、经济高效的巨量资料分析解决方案，降低了小规模实验室和机构的进入门槛。此外，这些技术的协同效应正在改善患者照护，为医疗专业人员提供有关遗传易感性的可操作信息，优化治疗方案，并提高整体医疗服务的效率。

市场区隔:

细分方式 1：依产品/服务

  • 生物资讯软体和工具
  • 生物资讯服务

生物资讯软体和工具在生物资讯市场（按产品/服务划分）中主导。

按产品和服务划分，全球生物资讯市场以生物资讯软体和工具为主导，预计到2024年将占据61.7%的市场份额。生物资讯软体和工具在管理、分析和解读复杂的生物数据方面发挥关键作用。随着次世代定序（NGS）等技术产生的资料量不断增长，这些工具能够实现高效的资料管理并加速分析流程。 BLAST和GATK等软体简化了序列比对、变异检测和突变检测等任务，这些任务对于基因组学和个人化医疗至关重要。此外，人工智慧和机器学习的融合提高了分析的准确性和预测能力，有助于检测基因突变和提案个人化治疗方法。 Illumina的BaseSpace Sequence Hub和Galaxy等云端基础平台透过促进协作并提供扩充性的资料共用和储存解决方案，进一步推动了生物资讯学的普及。这些工具对于推进基因组学、药物发现和精准医疗等领域至关重要，因为它们可以减少人工工作，提高速度，并确保在研究和临床环境中获得更准确的结果。

细分2：按行业

  • 医学生物技术
  • 动物生物技术
  • 植物生物技术
  • 法医学医学工程
  • 其他的

医疗生物技术推动生物资讯市场（按领域划分）

按行业划分，到2024年，医疗生物技术将以55.2%的市场份额引领全球生物资讯市场。医疗生物技术在生物资讯市场的主导源自于其广泛应用生物资讯学工具，以推动基因治疗、个人化医疗和药物研发等领域的发展。生物资讯学能够分析大规模基因组资料集，帮助生物技术公司识别与疾病相关的基因突变、生物标记和治疗标靶。例如，Illumina的定序平台在医疗生物技术领域至关重要，它提供的精准基因组数据推动了诊断和治疗研发的进步。精准医疗领域的领导者Tempus利用生物资讯分析癌症患者的基因谱，并根据个别突变推荐个人化治疗方案。此外，作为医疗生物技术核心技术的CRISPR-Cas9基因编辑也依赖生物资讯学进行精准的基因标靶化和检验。生物资讯学与医疗生物技术的融合加速了标靶治疗的研发，改善了治疗效果，并简化了药物发现流程。这种协同作用使生物资讯学成为医学生物技术成功和发展的重要组成部分。

细分 3：按应用

  • 基因组学
  • 蛋白质体学
  • 转录组学
  • 代谢体学
  • 其他的

基因组学推动生物资讯市场（按应用领域划分）

按应用领域划分，基因组学将在2024年占据全球生物资讯市场39.7%的份额。基因组学之所以主导生物资讯市场，是因为它会产生庞大而复杂的资料集，需要先进的生物资讯学工具进行精确的分析和解读。在基因组学领域，生物资讯学对于定序、比对和变异检测等任务至关重要，这些任务能够识别基因突变和潜在的治疗标靶。例如，Illumina的定序平台在基因组研究和临床应用中发挥核心作用，提供的数据驱动着个人化医疗和药物研发。像Tempus这样的公司利用生物资讯分析基因组数据，实现精准癌症治疗，根据基因突变客製化治疗方法。此外，生物资讯学工具对于人类基因组计画和千人基因组计划等大型基因组计划也至关重要，这些计画增进了我们对遗传学的理解，并为现代基因组学奠定了基础。随着基因组技术的不断发展，生物资讯学对于分析、解释和应用基因组数据仍然至关重要，这有助于基因组学在生物资讯市场中确立主导地位。

细分 4：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 其他地区

预计北美将在生物资讯市场中展现最高的区域成长。

北美在全球生物资讯市场占据领先地位，预计到2024年将占全球市场份额的约43.5%。北美在生物资讯市场的主导地位得益于其强大的基础设施、大规模的研发投入以及Illumina、Thermo Fisher Scientific和Qiagen等主要企业的存在。然而，亚太地区是生物资讯学领域成长最快的市场，这主要得益于不断扩大的医疗保健基础设施、生物技术和基因组学领域投资的增加以及对个人化医疗日益增长的需求。中国、印度和日本等国家正在大力投资基因组学研究和生物资讯技术，以满足不断增长的医疗保健需求。该地区庞大且多元化的人口为基因组学研究提供了丰富的数据，为精准医疗和药物研发的进步创造了机会。

全球生物资讯市场最新趋势

  • 2025 年 9 月，赛默飞世尔科技公司宣布与 BenchSci 建立策略伙伴关係，共同开发人工智慧驱动的工具，用于临床前研究和药物发现中的实验设计、优化试剂选择和数据解释。
  • 2025年5月，凯杰（QIAGEN）签署最终协议，收购人工智慧软体公司Genoox。 Genoox致力于简化复杂基因检测的分析流程。该协议将把Genoox的云端基础平台Franklin纳入凯杰数位洞察产品组合，从而巩固凯杰在临床基因组学和基因解读领域的领先地位。
  • 2025 年 2 月，QIAGEN 宣布在澳洲墨尔本正式启用一座新的资料中心，旨在加强公司在全球生物资讯学方面的能力，并扩大其在该地区的领先地位。

需求——驱动因素、挑战与机会

市场驱动因素：

药物发现领域对生物资讯学的需求日益增长——数据驱动和计算驱动的药物发现模式的兴起是推动全球生物资讯市场成长的主要因素。次世代定序、蛋白质体学、单细胞分析和代谢体学产生的多组体学数据的快速增长，显着提升了对能够整合、分析和解读复杂生物数据集的生物资讯平台的需求。这些工具透过加深我们对疾病机制的理解、改善目标分子识别以及利用广泛的基因组、蛋白质组和结构资料库进行高效的虚拟筛检，显着增强了早期研究。分子对接、虚拟筛检和基于人工智慧的电脑辅助药物设计（CADD）的广泛应用，透过减少传统实验流程所需的时间和成本，进一步推动了市场需求。诸如In Silico Medicine公司人工智慧设计的药物INS018_055进入II期临床试验等具有里程碑意义的成功案例，凸显了电脑辅助药物发现的商业性价值以及业界日益增长的信心。此外，对更快、更安全研发路径的需求推动了生物资讯学在药物发现领域的应用日益广泛，进而促使对预测演算法和药物-疾病匹配平台的投资不断增长。这些因素共同推动了生物资讯学与药物研发的融合，从而带动了生物资讯市场的强劲持续成长。

市场挑战：

数据复杂性和异质性：来自基因组学、转录组学、蛋白质组学、成像和临床系统的快速增长的多维数据集，给整合、分析和标准化带来了巨大挑战。数据复杂性和异质性仍然是生物资讯学市场的主要阻碍因素。各机构必须投入巨资购置先进的运算工具、高效能基础设施和专业知识，才能管理大型且多样化的资料类型，包括单一檔案大小达 100-200 GB 的全基因测序檔案、英国生物银行等Petabyte级资料库，以及包含数百万个细胞的单细胞资料集。从 DNA 到临床记录，生物资讯的多维特性进一步加剧了数据协调和因果关係解读的复杂性。由于平台差异、批次效应和取样方法不一致，研究人员往往需要花费数週时间来协调多体学资料。异质资料格式（FASTQ、BAM、DICOM、mzML、PDB）和不相容的临床标准（HL7、FHIR、ICD-10、SNOMED）阻碍了互通性，而资料品质参差不齐和缺乏标准化元资料则增加了预处理负担。蛋白质体学实验室和大型联盟（例如ELIXIR和GA4GH）经常报告这些问题。即使是辉瑞和诺华等大型製药企业，由于整合多体学、影像学和真实世界资料集的挑战，在早期研发阶段也面临数月的延误。总而言之，这些问题对可扩展性构成了重大障碍，延长了研究週期，并限制了生物资讯解决方案的广泛应用。这使得数据复杂性和异质性成为市场成长的主要阻碍因素。

市场机会

总体基因体学的新兴角色——生物资讯学在总体基因体学中扮演着日益重要的角色，它提供了分析大型复杂数据集、识别微生物群落及其功能所需的计算能力。从16S rRNA定序到鸟枪法宏基因组学的转变加速了这一趋势，实现了物种和菌株水平的分辨率、功能通路註释以及抗菌素抗药性的即时追踪。诸如2024年《生物资讯学杂誌》一项研究中重点介绍的Nanometa Live平台等先进工具，现在可以透过互动式和自动化工作流程支援病原体的即时检测。在临床诊断领域，牛津奈米孔技术公司的mNGS流程和可携式定序仪能够快速现场鑑定细菌、病毒和真菌，从而改善疫情爆发和混合感染的应对措施。在环境和农业领域，元基因组生物资讯学正被应用于水质监测、土壤和海洋微生物组图谱绘製以及靶向生物肥料的开发。多体学数据的日益整合将进一步扩大其在酶发现、生质燃料生产、生物修復和治疗方法开发等领域的应用，使总体基因体学成为全球生物资讯市场中快速成长的机会。

这份报告能为贵公司带来哪些价值？

产品与创新策略：全球生物资讯市场已根据产品和服务、产业、应用和地区等各种类别进行了详细细分，这有助于读者清楚地了解哪些细分市场占据最大份额，以及预计未来几年它们将在哪些领域成长。

成长与行销策略：产品发布是主要发展的主要因素，约占 2023 年 1 月至 2025 年 11 月全球生物资讯市场所有发展总量的 51%。

竞争策略：全球生物资讯市场拥有众多产品系列完善的成熟企业。本研究分析和介绍的全球生物资讯学市场主要参与者均为提供生物资讯学产品和服务的成熟公司。

调查方法

市场设计与检验中的关键考虑因素与假设

  • 为估算全球市场规模，我们考虑了 2023 年至 2035 年期间，其中 2024 年为基准年，2025 年至 2035 年为预测期。
  • 本报告的范围是根据全球各公司专家的见解精心製定的，它对生物资讯市场的产品和服务进行了全面的市场研究。
  • 预计生物资讯学的市场贡献将在未来稳步增长，该预测是基于对现有解决方案的历史分析。
  • 公司收入数据来自 2023 财年和 2024 财年的年度报告。对于私人公司，收入是根据一手调查数据、资金筹措历史、市场联繫和业务表现估算的。
  • 本报告基于现有的生物资讯学产品和服务绘製了市场图。报告中已识别并介绍了该领域的主要企业及其重要产品和服务。

主要市场参与企业及竞争摘要

本次评选的公司是根据对公司覆盖范围、产品系列和市场渗透率的分析所得出的资讯而选定的。

该市场的主要企业有：

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • QIAGEN
  • ArrayGen Technologies Pvt. Ltd.
  • Source BioScience

目录

执行摘要

第一章 全球生物资讯学市场：产业展望

  • 市场趋势：当前及未来影响评估
    • 人工智慧和机器学习在生物资讯解决方案中的策略整合
    • 将多体学数据整合到生物资讯市场
    • 量子计算变革生物资讯学
  • 监管状态
  • 定价分析
  • 市场动态
    • 市场驱动因素
    • 市场挑战
    • 市场机会

第二章 全球生物资讯市场（按产品和服务划分，单位：十亿美元，2023-2035 年）

  • 生物资讯软体和工具
  • 生物资讯服务
    • 定序和数据生成服务
    • 资料库建置和管理服务
    • 数据分析与解释服务
    • 其他的

3. 全球生物资讯市场（按产业划分）（十亿美元，2023-2035 年）

  • 医学生物技术
  • 动物生物技术
  • 植物生物技术
  • 法医学生物技术
  • 其他的

4. 全球生物资讯市场按应用领域划分，单位：十亿美元，2023-2035年

  • 基因组学
  • 蛋白质体学
  • 转录组学
  • 代谢体学
  • 其他的

5. 全球生物资讯市场（按地区划分，单位：十亿美元），2023-2035年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第六章 竞争基准化分析与公司概况

  • 2023-2025年主要策略与发展
  • 关键发展分析（依公司划分），2023-2025 年
  • 公司简介
    • Agilent Technologies
    • ArrayGen Technologies Pvt. Ltd.
    • BGI Group
    • Crown Bioscience
    • Danaher Corporation (Genedata AG)
    • DNASTAR
    • Eurofins Scientific
    • Fios Genomics
    • Illumina, Inc.
    • MedGenome
    • Nucleome Informatics
    • Psomagen Inc.
    • QIAGEN
    • SOPHiA GENETICS
    • Thermo Fisher Scientific Inc.

第七章调查方法

Product Code: BHD3397SA

This report can be delivered within 1 working day.

Introduction of the Bioinformatics Market

The global bioinformatics market, initially valued at $14.23 billion in 2024, is projected to witness substantial growth, surging to $55.54 billion by 2035, marking a remarkable compound annual growth rate (CAGR) of 13.21% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$16.06 Billion
2035 Forecast$55.54 Billion
CAGR13.21%

Bioinformatics is an interdisciplinary field that combines biology, chemistry, mathematics, statistics, and computer science to analyze complex biological data. It is essential for understanding the structure, function, and evolution of biological molecules and systems, playing a key role in identifying genetic causes of diseases, analyzing gene expression, and studying protein interactions. Bioinformatics is also crucial in drug discovery, personalized medicine, and the exploration of metabolic pathways. The rapid growth of genomic data, driven by advances in next-generation sequencing technologies, has significantly boosted the demand for bioinformatics tools. Additionally, bioinformatics is increasingly applied in precision medicine. The field's importance continues to rise, with ongoing advancements in AI and machine learning further enhancing the accuracy and speed of data analysis, making bioinformatics a critical component in the future of healthcare, genomics, and life sciences research.

Market Introduction

The bioinformatics market has been rapidly advancing, driven by technological innovations and increasing investments in genomics and personalized medicine. Key companies such as Illumina Inc., Thermo Fisher Scientific Inc., and QIAGEN are at the forefront of bioinformatics solutions, offering cutting-edge sequencing platforms and data analysis tools that are transforming the healthcare and pharmaceutical industries. Strategic collaborations and acquisitions are also playing a significant role in market growth. For instance, Illumina has expanded its footprint in the APAC region, while Thermo Fisher Scientific Inc. continues to innovate with cloud-based bioinformatics solutions for genomic data analysis. Additionally, companies like Tempus and 23andMe are integrating bioinformatics tools for precision medicine and consumer genetic testing, driving the adoption of bioinformatics across diverse applications. These developments highlight the increasing demand for advanced bioinformatics solutions, fueling innovation and expanding applications in genomics, drug discovery, and personalized healthcare.

Industrial Impact

The bioinformatics market has been experiencing a significant transformation, largely driven by key players such as Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, and QIAGEN, who are at the forefront of advancing bioinformatics technologies. These leaders are pushing the boundaries of innovation, integrating cutting-edge technologies such as Artificial Intelligence (AI), machine learning, and cloud computing to enhance bioinformatics capabilities. The integration of AI in bioinformatics is revolutionizing the analysis of complex biological data, enabling researchers and clinicians to make faster, more accurate insights into genomics, proteomics, and personalized medicine.

AI-driven bioinformatics tools are automating data processing and analysis, reducing human error and expediting research timelines. For example, AI models can analyze vast genomic datasets to identify patterns and mutations linked to diseases, which would take traditional methods much longer to uncover. This rapid analysis is crucial for advancing precision medicine, where treatments are tailored to the genetic profile of individual patients. Additionally, machine learning algorithms are enhancing predictive models, allowing for more accurate forecasts in drug development and patient outcomes.

The adoption of cloud computing in bioinformatics has also been transformative, enabling seamless data sharing, storage, and collaboration across global research teams. This has not only accelerated research and development in genomics and drug discovery but also lowered the barrier to entry for smaller labs and institutions by providing scalable, cost-effective solutions for big data analysis. Furthermore, the synergy of these technologies is improving patient care by providing healthcare providers with actionable insights into genetic predispositions, optimizing treatment plans, and enhancing the overall efficiency of healthcare delivery.

Market Segmentation:

Segmentation 1: By Product and Services

  • Bioinformatics Software and Tools
  • Bioinformatics Services

Bioinformatics Software and Tools to Dominate the Bioinformatics Market (by Product and Services)

Based on product and services, the global bioinformatics market was led by bioinformatics software and tools, which held a 61.7% share in 2024. Bioinformatics software and tools play a critical role in managing, analyzing, and interpreting complex biological data. With the increasing volume of data from technologies like next-generation sequencing (NGS), these tools enable efficient data management and accelerate the analysis process. Software like BLAST and GATK streamline tasks such as sequence alignment, variant calling, and mutation detection, which are essential for genomics and personalized medicine. Furthermore, the integration of AI and machine learning enhances the accuracy and predictive power of analyses, which helps in detecting genetic variants and providing personalized treatment recommendations. Cloud-based platforms like Illumina's BaseSpace Sequence Hub and Galaxy have further democratized bioinformatics by enabling collaboration and providing scalable solutions for data sharing and storage. These tools reduce manual effort, improve speed, and ensure more precise outcomes in research and clinical settings, making them indispensable for advancing fields such as genomics, drug discovery, and precision medicine.

Segmentation 2: By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Forensic Biotechnology
  • Others

Medical Biotechnology to Dominate the Bioinformatics Market (by Sector)

Based on sector, medical biotechnology dominated the global bioinformatics market with a 55.2% share in 2024. Medical biotechnology dominates the bioinformatics market because it relies heavily on bioinformatics tools to advance areas like gene therapy, personalized medicine, and drug development. Bioinformatics enables the analysis of large genomic datasets, allowing biotech companies to identify disease-related genetic mutations, biomarkers, and therapeutic targets. For example, Illumina's sequencing platforms are essential in medical biotechnology, providing accurate genomic data that drives advancements in diagnostics and treatment development. Tempus, a leader in precision medicine, uses bioinformatics to analyze genetic profiles of cancer patients, offering personalized treatment recommendations based on their unique mutations. Additionally, CRISPR-Cas9 gene editing, a key technology in medical biotech, depends on bioinformatics for precise gene targeting and validation. The combination of bioinformatics with medical biotechnology accelerates the development of targeted therapies, improving treatment outcomes and enhancing drug discovery processes. This synergy has made bioinformatics an integral part of medical biotechnology's success and growth.

Segmentation 3: By Application

  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Genomics to Lead the Bioinformatics Market (by Application)

Based on application, genomics dominated the global bioinformatics market with a 39.7% share in 2024. Genomics dominates the bioinformatics market because it generates vast, complex datasets that require advanced bioinformatics tools for accurate analysis and interpretation. Bioinformatics is crucial in genomics for tasks such as sequencing, alignment, and variant calling, enabling the identification of genetic mutations and potential therapeutic targets. For instance, Illumina's sequencing platforms are central to genomic research and clinical applications, providing data that drives personalized medicine and drug development. Companies like Tempus leverage bioinformatics to analyze genomic data for precision cancer treatment, tailoring therapies based on genetic mutations. Additionally, bioinformatics tools are integral to large-scale genomic projects like the Human Genome Project and the 1000 Genomes Project, which have expanded our understanding of genetics and laid the foundation for modern genomics. As genomic technologies continue to advance, bioinformatics remains essential for analyzing, interpreting, and applying genomic data, solidifying genomics' dominance in the bioinformatics market.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Rest-of-the-World

North America to Witness the Highest Growth in the Bioinformatics Market (by Region)

The bioinformatics market in North America dominates globally, accounting for approximately 43.5% share in 2024. North America dominates the bioinformatics market due to its strong infrastructure, significant R&D investments, and the presence of leading companies like Illumina, Thermo Fisher Scientific, and QIAGEN. However, the Asia-Pacific region is the fastest-growing market in bioinformatics due to its expanding healthcare infrastructure, increasing investments in biotechnology and genomics, and a rising demand for personalized medicine. Countries like China, India, and Japan are heavily investing in genomic research and bioinformatics technologies to support their growing healthcare needs. The region's large, diverse population provides a wealth of data for genomic studies, creating opportunities for advancements in precision medicine and drug development.

Recent Developments in the Global Bioinformatics Market

  • In September 2025, Thermo Fisher Scientific Inc. announced a strategic partnership with BenchSci to develop AI-powered tools for experimental design, optimized reagent selection, and data interpretation in preclinical research and drug discovery.
  • In May 2025, QIAGEN signed a definitive agreement to acquire Genoox, an AI-powered software company that streamlines complex genetic test analysis. The deal adds Franklin, Genoox's cloud-based platform, to the QIAGEN Digital Insights portfolio, bolstering QIAGEN's leadership in clinical genomics and genetic interpretation.
  • In February 2025, QIAGEN announced the official launch of its new data center in Melbourne, Australia, aimed at enhancing the company's global bioinformatics capabilities and reinforcing its leadership in the region.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Growing Demand for Bioinformatics in Drug Discovery: The increasing shift toward data-driven and computational drug development is a primary driver accelerating the growth of the global bioinformatics market. The rapid expansion of multi-omics data generated through next-generation sequencing, proteomics, single-cell analysis, and metabolomics has created a critical need for bioinformatics platforms that can integrate, analyze, and interpret complex biological datasets. These tools significantly enhance early-stage research by deepening understanding of disease mechanisms, improving target identification, and enabling efficient virtual screening using extensive genomic, proteomic, and structural databases. The widespread adoption of molecular docking, virtual screening, and AI-enabled computer-aided drug design (CADD) further amplifies market demand, as these technologies reduce both the time and cost associated with traditional experimental workflows. High-impact examples, such as Insilico Medicine's AI-designed INS018_055 advancing to Phase II trials, highlight the commercial value and growing industry confidence in computational drug discovery. Additionally, the rising use of bioinformatics for drug repurposing, driven by the need for faster, lower-risk development pathways, is expanding investment in predictive algorithms and drug-disease matching platforms. Together, these factors underscore how the increasing integration of bioinformatics into pharmaceutical R&D is driving robust and sustained growth in the bioinformatics market.

Market Challenges:

Data Complexity and Heterogeneity: Data complexity and heterogeneity remain major restraints in the bioinformatics market, as rapidly expanding and multi-dimensional datasets from genomics, transcriptomics, proteomics, imaging, and clinical systems are difficult to integrate, analyze, and standardize. Organizations must invest heavily in advanced computational tools, high-performance infrastructure, and specialized expertise to manage large and diverse data types such as whole-genome sequencing files reaching 100-200 GB each, multi-petabyte repositories like the U.K. Biobank, and single-cell datasets containing millions of cells. The multi-dimensional nature of biological information, spanning DNA to clinical records, further complicates harmonization and causal interpretation, with researchers often spending weeks aligning multi-omics layers due to cross-platform variability, batch effects, and inconsistent sampling methods. Heterogeneous data formats (FASTQ, BAM, DICOM, mzML, PDB) and incompatible clinical standards (HL7, FHIR, ICD-10, SNOMED) hinder interoperability, while variable data quality and lack of standardized metadata add to preprocessing burdens, issues frequently reported by proteomics labs and large consortia like ELIXIR and GA4GH. Even major pharmaceutical companies such as Pfizer and Novartis face delays of months in early-stage development due to challenges in integrating multi-omics, imaging, and real-world clinical datasets. Collectively, these issues create significant barriers to scalability, prolong research timelines, and restrict wider adoption of bioinformatics solutions, making data complexity and heterogeneity key restraints on market growth.

Market Opportunities

Emerging Role in Metagenomics: Bioinformatics is becoming increasingly vital in metagenomics, providing the computational power needed to analyze large, complex datasets and identify microbial communities and their functions. The shift from 16S rRNA sequencing to shotgun metagenomics has accelerated this trend, enabling species- and strain-level resolution, functional pathway annotation, and real-time tracking of antimicrobial resistance. Advanced tools such as the Nanometa Live platform, highlighted in a 2024 Bioinformatics Journal study, now support real-time pathogen detection through interactive and automated workflows. In clinical diagnostics, mNGS pipelines and portable sequencers from Oxford Nanopore Technologies allow rapid, on-site identification of bacteria, viruses, and fungi, improving responses during outbreaks and mixed infections. Environmental and agricultural sectors are adopting metagenomic bioinformatics to monitor water quality, map soil and ocean microbiomes, and develop targeted biofertilizers. Growing integration of multi-omics data is further expanding applications in enzyme discovery, biofuel production, bioremediation, and therapeutic development, positioning metagenomics as a rapidly growing opportunity within the global bioinformatics market.

How can this report add value to an organization?

Product/Innovation Strategy: The global bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Product launches have accounted for the majority of key developments, comprising nearly 51% of the total developments in the global bioinformatics market between January 2023 and November 2025.

Competitive Strategy: The global bioinformatics market has numerous established players with product portfolios. Key players in the global bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2023 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The scope of this report has been carefully developed based on insights from experts across various companies worldwide. It presents a comprehensive market study of the products and services withing bioinformatics market.
  • The market contribution of bioinformatics is anticipated to grow steadily in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates have been derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing bioinformatics products and services. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts in bioinformatics, including the market players offering products and services. Resources such as CEOs, vice presidents, and marketing directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • QIAGEN
  • ArrayGen Technologies Pvt. Ltd.
  • Source BioScience

Table of Contents

Executive Summary

Scope and Definition

1 Global Bioinformatics Market: Industry Outlook

  • 1.1 Market Trends: Current and Future Impact Assessment
    • 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
    • 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
    • 1.1.3 Quantum Computing to Transform Bioinformatics
  • 1.2 Regulatory Landscape
  • 1.3 Pricing Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Market Drivers
      • 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
      • 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
      • 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
    • 1.4.2 Market Challenges
      • 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
      • 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
    • 1.4.3 Market Opportunities
      • 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics

2 Global Bioinformatics Market, by Product and Services, $Billion, 2023-2035

  • 2.1 Bioinformatics Software and Tools
  • 2.2 Bioinformatics Services
    • 2.2.1 Sequencing and Data Generation Services
    • 2.2.2 Database Construction and Management Services
    • 2.2.3 Data Analysis and Interpretation Services
    • 2.2.4 Others

3 Global Bioinformatics Market, by Sector, $Billion, 2023-2035

  • 3.1 Medical Biotechnology
  • 3.2 Animal Biotechnology
  • 3.3 Plant Biotechnology
  • 3.4 Forensic Biotechnology
  • 3.5 Others

4 Global Bioinformatics Market, by Application, $Billion, 2023-2035

  • 4.1 Genomics
  • 4.2 Proteomics
  • 4.3 Transcriptomics
  • 4.4 Metabolomics
  • 4.5 Other Applications

5 Global Bioinformatics Market, by Region, $Billion, 2023-2035

  • 5.1 North America
    • 5.1.1 Regional Overview
    • 5.1.2 Driving Factors for Market Growth
    • 5.1.3 Factors Challenging the Market
    • 5.1.4 Market Sizing and Forecast
      • 5.1.4.1 North America Bioinformatics Market (by Product and Services)
      • 5.1.4.2 North America Bioinformatics Market (by Application)
      • 5.1.4.3 North America Bioinformatics Market (by Sector)
      • 5.1.4.4 North America Bioinformatics Market (by Country)
        • 5.1.4.4.1 U.S.
          • 5.1.4.4.1.1 Country Overview
          • 5.1.4.4.1.2 Driving Factors Market Growth
          • 5.1.4.4.1.3 Factors Challenging the Market
          • 5.1.4.4.1.4 Analyst View
          • 5.1.4.4.1.5 Market Sizing and Forecast
        • 5.1.4.4.2 Canada
          • 5.1.4.4.2.1 Country Overview
          • 5.1.4.4.2.2 Driving Factors Market Growth
          • 5.1.4.4.2.3 Factors Challenging the Market
          • 5.1.4.4.2.4 Analyst View
          • 5.1.4.4.2.5 Market Sizing and Forecast
  • 5.2 Europe
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Analyst View
    • 5.2.5 Market Sizing and Forecast
      • 5.2.5.1 Europe Bioinformatics Market (by Product and Services)
      • 5.2.5.2 Europe Bioinformatics Market (by Application)
      • 5.2.5.3 Europe Bioinformatics Market (by Sector)
      • 5.2.5.4 Europe Bioinformatics Market (by Country)
        • 5.2.5.4.1 U.K.
          • 5.2.5.4.1.1 Country Overview
          • 5.2.5.4.1.2 Driving Factors Market Growth
          • 5.2.5.4.1.3 Factors Challenging the Market
          • 5.2.5.4.1.4 Analyst View
          • 5.2.5.4.1.5 Market Sizing and Forecast
        • 5.2.5.4.2 Germany
          • 5.2.5.4.2.1 Country Overview
          • 5.2.5.4.2.2 Driving Factors Market Growth
          • 5.2.5.4.2.3 Factors Challenging the Market
          • 5.2.5.4.2.4 Analyst View
          • 5.2.5.4.2.5 Market Sizing and Forecast
        • 5.2.5.4.3 France
          • 5.2.5.4.3.1 Country Overview
          • 5.2.5.4.3.2 Driving Factors Market Growth
          • 5.2.5.4.3.3 Factors Challenging the Market
          • 5.2.5.4.3.4 Analyst View
          • 5.2.5.4.3.5 Market Sizing and Forecast
        • 5.2.5.4.4 Italy
          • 5.2.5.4.4.1 Country Overview
          • 5.2.5.4.4.2 Driving Factors Market Growth
          • 5.2.5.4.4.3 Factors Challenging the Market
          • 5.2.5.4.4.4 Analyst View
          • 5.2.5.4.4.5 Market Sizing and Forecast
        • 5.2.5.4.5 Spain
          • 5.2.5.4.5.1 Country Overview
          • 5.2.5.4.5.2 Driving Factors Market Growth
          • 5.2.5.4.5.3 Factors Challenging the Market
          • 5.2.5.4.5.4 Analyst View
          • 5.2.5.4.5.5 Market Sizing and Forecast
        • 5.2.5.4.6 Rest-of-Europe
          • 5.2.5.4.6.1 Regional Overview
          • 5.2.5.4.6.2 Driving Factors Market Growth
          • 5.2.5.4.6.3 Factors Challenging the Market
          • 5.2.5.4.6.4 Analyst View
          • 5.2.5.4.6.5 Market Sizing and Forecast
  • 5.3 Asia-Pacific
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Market Sizing and Forecast
      • 5.3.4.1 Asia-Pacific Bioinformatics Market (by Product and Services)
      • 5.3.4.2 Asia-Pacific Bioinformatics Market (by Application)
      • 5.3.4.3 Asia-Pacific Bioinformatics Market (by Sector)
      • 5.3.4.4 Asia-Pacific Bioinformatics Market (by Country)
        • 5.3.4.4.1 China
          • 5.3.4.4.1.1 Country Overview
          • 5.3.4.4.1.2 Driving Factors Market Growth
          • 5.3.4.4.1.3 Factors Challenging the Market
          • 5.3.4.4.1.4 Analyst View
          • 5.3.4.4.1.5 Market Sizing and Forecast
        • 5.3.4.4.2 Japan
          • 5.3.4.4.2.1 Country Overview
          • 5.3.4.4.2.2 Driving Factors Market Growth
          • 5.3.4.4.2.3 Factors Challenging the Market
          • 5.3.4.4.2.4 Analyst View
          • 5.3.4.4.2.5 Market Sizing and Forecast
        • 5.3.4.4.3 India
          • 5.3.4.4.3.1 Country Overview
          • 5.3.4.4.3.2 Driving Factors Market Growth
          • 5.3.4.4.3.3 Factors Challenging the Market
          • 5.3.4.4.3.4 Analyst View
          • 5.3.4.4.3.5 Market Sizing and Forecast
        • 5.3.4.4.4 South Korea
          • 5.3.4.4.4.1 Country Overview
          • 5.3.4.4.4.2 Driving Factors Market Growth
          • 5.3.4.4.4.3 Factors Challenging the Market
          • 5.3.4.4.4.4 Analyst View
          • 5.3.4.4.4.5 Market Sizing and Forecast
        • 5.3.4.4.5 Australia
          • 5.3.4.4.5.1 Country Overview
          • 5.3.4.4.5.2 Driving Factors Market Growth
          • 5.3.4.4.5.3 Factors Challenging the Market
          • 5.3.4.4.5.4 Analyst View
          • 5.3.4.4.5.5 Market Sizing and Forecast
        • 5.3.4.4.6 Rest-of-Asia-Pacific
          • 5.3.4.4.6.1 Country Overview
          • 5.3.4.4.6.2 Driving Factors Market Growth
          • 5.3.4.4.6.3 Factors Challenging the Market
          • 5.3.4.4.6.4 Analyst View
          • 5.3.4.4.6.5 Market Sizing and Forecast
  • 5.4 Rest-of-the-World
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Market Sizing and Forecast
      • 5.4.4.1 Rest-of-the-World Bioinformatics Market (by Product and Services)
      • 5.4.4.2 Rest-of-the-World Bioinformatics Market (by Application)
      • 5.4.4.3 Rest-of-the-World Bioinformatics Market (by Sector)

6 Competitive Benchmarking and Company Profiles

  • 6.1 Key Strategies and Developments, 2023-2025
  • 6.2 Key Developments Analysis (by Company), 2023-2025
  • 6.3 Company Profiles
    • 6.3.1 Agilent Technologies
      • 6.3.1.1 Overview
      • 6.3.1.2 Top Products/Product Portfolio
      • 6.3.1.3 Top Competitors
      • 6.3.1.4 Target Customers
      • 6.3.1.5 Key Personnel
      • 6.3.1.6 Analyst View
    • 6.3.2 ArrayGen Technologies Pvt. Ltd.
      • 6.3.2.1 Overview
      • 6.3.2.2 Top Products/Product Portfolio
      • 6.3.2.3 Top Competitors
      • 6.3.2.4 Target Customers
      • 6.3.2.5 Key Personnel
      • 6.3.2.6 Analyst View
    • 6.3.3 BGI Group
      • 6.3.3.1 Overview
      • 6.3.3.2 Top Products/Product Portfolio
      • 6.3.3.3 Top Competitors
      • 6.3.3.4 Target Customers
      • 6.3.3.5 Key Personnel
      • 6.3.3.6 Analyst View
    • 6.3.4 Crown Bioscience
      • 6.3.4.1 Overview
      • 6.3.4.2 Top Products/Product Portfolio
      • 6.3.4.3 Top Competitors
      • 6.3.4.4 Target Customers
      • 6.3.4.5 Key Personnel
      • 6.3.4.6 Analyst View
    • 6.3.5 Danaher Corporation (Genedata AG)
      • 6.3.5.1 Overview
      • 6.3.5.2 Top Products/Product Portfolio
      • 6.3.5.3 Top Competitors
      • 6.3.5.4 Target Customers
      • 6.3.5.5 Key Personnel
      • 6.3.5.6 Analyst View
    • 6.3.6 DNASTAR
      • 6.3.6.1 Overview
      • 6.3.6.2 Top Products/Product Portfolio
      • 6.3.6.3 Top Competitors
      • 6.3.6.4 Target Customers
      • 6.3.6.5 Key Personnel
      • 6.3.6.6 Analyst View
    • 6.3.7 Eurofins Scientific
      • 6.3.7.1 Overview
      • 6.3.7.2 Top Products/Product Portfolio
      • 6.3.7.3 Top Competitors
      • 6.3.7.4 Target Customers
      • 6.3.7.5 Key Personnel
      • 6.3.7.6 Analyst View
    • 6.3.8 Fios Genomics
      • 6.3.8.1 Overview
      • 6.3.8.2 Top Products/Product Portfolio
      • 6.3.8.3 Top Competitors
      • 6.3.8.4 Target Customers
      • 6.3.8.5 Key Personnel
      • 6.3.8.6 Analyst View
    • 6.3.9 Illumina, Inc.
      • 6.3.9.1 Overview
      • 6.3.9.2 Top Products/Product Portfolio
      • 6.3.9.3 Top Competitors
      • 6.3.9.4 Target Customers
      • 6.3.9.5 Key Personnel
      • 6.3.9.6 Analyst View
    • 6.3.10 MedGenome
      • 6.3.10.1 Overview
      • 6.3.10.2 Top Products/Product Portfolio
      • 6.3.10.3 Top Competitors
      • 6.3.10.4 Target Customers
      • 6.3.10.5 Key Personnel
      • 6.3.10.6 Analyst View
    • 6.3.11 Nucleome Informatics
      • 6.3.11.1 Overview
      • 6.3.11.2 Top Products/Product Portfolio
      • 6.3.11.3 Top Competitors
      • 6.3.11.4 Target Customers
      • 6.3.11.5 Key Personnel
      • 6.3.11.6 Analyst View
    • 6.3.12 Psomagen Inc.
      • 6.3.12.1 Overview
      • 6.3.12.2 Top Products/Product Portfolio
      • 6.3.12.3 Top Competitors
      • 6.3.12.4 Target Customers
      • 6.3.12.5 Key Personnel
      • 6.3.12.6 Analyst View
    • 6.3.13 QIAGEN
      • 6.3.13.1 Overview
      • 6.3.13.2 Top Products/Product Portfolio
      • 6.3.13.3 Top Competitors
      • 6.3.13.4 Target Customers
      • 6.3.13.5 Key Personnel
      • 6.3.13.6 Analyst View
    • 6.3.14 SOPHiA GENETICS
      • 6.3.14.1 Overview
      • 6.3.14.2 Top Products/Product Portfolio
      • 6.3.14.3 Top Competitors
      • 6.3.14.4 Target Customers
      • 6.3.14.5 Key Personnel
      • 6.3.14.6 Analyst View
    • 6.3.15 Thermo Fisher Scientific Inc.
      • 6.3.15.1 Overview
      • 6.3.15.2 Top Products/Product Portfolio
      • 6.3.15.3 Top Competitors
      • 6.3.15.4 Target Customers
      • 6.3.15.5 Key Personnel
      • 6.3.15.6 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Bioinformatics Market (by Scenario), $Billion, 2024, 2025, and 2035
  • Figure 2: Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 3: Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 4: Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 5: Global Bioinformatics Market, $Billion, 2024 and 2035
  • Figure 6: Global Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 7: Global Bioinformatics Market (Bioinformatics Software and Tools), $Billion, 2023-2035
  • Figure 8: Global Bioinformatics Market (by Bioinformatics Services), $Billion, 2023-2035
  • Figure 9: Global Bioinformatics Market (Sequencing and Data Generation Services), $Billion, 2023-2035
  • Figure 10: Global Bioinformatics Market (Database Construction and Management Services), $Billion, 2023-2035
  • Figure 11: Global Bioinformatics Market (Data Analysis and Interpretation Services), $Billion, 2023-2035
  • Figure 12: Global Bioinformatics Market (Others), $Billion, 2023-2035
  • Figure 13: Global Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 14: Global Bioinformatics Market (Medical Biotechnology), $Billion, 2023-2035
  • Figure 15: Global Bioinformatics Market (Animal Biotechnology), $Billion, 2023-2035
  • Figure 16: Global Bioinformatics Market (Plant Biotechnology), $Billion, 2023-2035
  • Figure 17: Global Bioinformatics Market (Forensic Biotechnology), $Billion, 2023-2035
  • Figure 18: Global Bioinformatics Market (Others), $Billion, 2023-2035
  • Figure 19: Global Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 20: Global Bioinformatics Market (Genomics), $Billion, 2023-2035
  • Figure 21: Global Bioinformatics Market (Proteomics), $Billion, 2023-2035
  • Figure 22: Global Bioinformatics Market (Transcriptomics), $Billion, 2023-2035
  • Figure 23: Global Bioinformatics Market (Metabolomics), $Billion, 2023-2035
  • Figure 24: Global Bioinformatics Market (Other Applications), $Billion, 2023-2035
  • Figure 25: North America Bioinformatics Market, $Billion, 2023-2035
  • Figure 26: U.S. Bioinformatics Market, $Billion, 2023-2035
  • Figure 27: Canada Bioinformatics Market, $Billion, 2023-2035
  • Figure 28: Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 29: U.K. Bioinformatics Market, $Billion, 2023-2035
  • Figure 30: Germany Bioinformatics Market, $Billion, 2023-2035
  • Figure 31: France Bioinformatics Market, $Billion, 2023-2035
  • Figure 32: Italy Bioinformatics Market, $Billion, 2023-2035
  • Figure 33: Spain Bioinformatics Market, $Billion, 2023-2035
  • Figure 34: Rest-of-Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 35: Asia-Pacific Bioinformatics Market, $Billion, 2023-2035
  • Figure 36: China Bioinformatics Market, $Billion, 2023-2035
  • Figure 37: Japan Bioinformatics Market, $Billion, 2023-2035
  • Figure 38: India Bioinformatics Market, $Billion, 2023-2035
  • Figure 39: South Korea Bioinformatics Market, $Billion, 2023-2035
  • Figure 40: Australia Bioinformatics Market, $Billion, 2023-2035
  • Figure 41: Rest-of-Asia-Pacific Bioinformatics Market, $Billion, 2023-2035
  • Figure 42: Rest-of-the-World Bioinformatics Market, $Billion, 2023-2035
  • Figure 43: Key Strategies and Developments, January 2023-November 2025
  • Figure 44: Data Triangulation
  • Figure 45: Top-Down and Bottom-Up Approach
  • Figure 46: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Global Bioinformatics Market, Regulatory Landscape
  • Table 4: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • Table 5: Some of the Public and Private Funding in the Bioinformatics Industry
  • Table 6: Global Bioinformatics Market (by Region), $Billion, 2023-2035
  • Table 7: North America Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 8: North America Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 9: North America Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 10: North America Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 11: U.S. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 12: U.S. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 13: U.S. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 14: Canada Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 15: Canada Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 16: Canada Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 17: Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 18: Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 19: Europe Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 20: Europe Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 21: U.K. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 22: U.K. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 23: U.K. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 24: Germany Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 25: Germany Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 26: Germany Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 27: France Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 28: France Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 29: France Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 30: Italy Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 31: Italy Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 32: Italy Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 33: Spain Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 34: Spain Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 35: Spain Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 36: Rest-of-Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 37: Rest-of-Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 38: Rest-of-Europe Bioinformatics Market (by Sector), $Billion, 2024-3-2035
  • Table 39: Asia-Pacific Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 40: Asia-Pacific Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 41: Asia-Pacific Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 42: Asia-Pacific Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 43: China Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 44: China Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 45: China Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 46: Japan Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 47: Japan Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 48: Japan Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 49: India Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 50: India Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 51: India Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 52: South Korea Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 53: South Korea Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 54: South Korea Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 55: Australia Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 56: Australia Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 57: Australia Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 58: Rest-of-Asia-Pacific Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 59: Rest-of-Asia-Pacific Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 60: Rest-of-Asia-Pacific Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 61: Rest-of-the-World Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 62: Rest-of-the-World Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 63: Rest-of-the-World Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 64: Key Strategies and Developments, 2023-2025